Month: April 2021

07/04/2021 LACROIX présente LEADERSHIP 2025, son nouveau plan stratégique Des ambitions fortes :Devenir un leader international des solutions IoT industrielles etdes équipements électroniques pour les applications critiques. Accélérer et changer de dimension d’ici 2025800 M€ de chiffre d’affaires et une marge d’EBITDA1 d’environ 9%. « Depuis 2016, notre Groupe s’est engagé dans une transformation en profondeur qui lui aura notamment permis de renforcer ses expertises technologiques et de s’inscrire dans une trajectoire solide de croissance et de progression de ses résultats. Grâce à ces fondations, nous avons pu démontrer notre résilience face à la crise sans précédent qui a marqué l’année 2020. Nous sommes prêts à nous projeter à nouveau vers l’avenir, animés par des ambitions fortes qui porteront notre développement pour les cinq prochaines...

  Communiqué de presse Paris, le 7 avril 2021 Entrée en négociation exclusive en vue de l’acquisition de Lyxor par Amundi Amundi annonce être entrée en négociation exclusive avec Société Générale en vue de l’acquisition de Lyxor1 pour un prix en numéraire de 825 M€ (soit 755 M€ hors capital excédentaire)2. Fondé en 1998 et pionnier des ETF en Europe, Lyxor gère 124 Md€ d’encours3. Lyxor est l’un des acteurs majeurs sur le marché des ETF (77 Md€ d’encours4, 3e acteur en Europe avec une part de marché de 7,4%5) et dispose  d’expertises reconnues  en gestion active (47 Md€), notamment à travers sa plateforme de gestion alternative de premier plan6. Avec cette opération, Amundi deviendrait le leader européen de la gestion des ETF,  avec 142 Md€ d’encours combinés, une part de marché de 14% en Europe7, et un profil diversifié tant en terme...

Anti-p53 antibodies are antibodies that mistakenly target a patient’s own tissues, leading to a growth of solid tumors. Screening for Anti-p53 helps to diagnose throat, bowel and breast cancers earlier, thereby increasing the chances that a patient responds to a treatment The Elecsys Anti-p53 could be used to monitor cancer cell remnants in the patient’s bodyBasel, 07 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys Anti-p53 immunoassay for the in vitro quantitative determination of anti-p53 antibodies. This test is used to aid physicians to diagnose throat cancer, bowel cancer and breast cancer in patients, in conjunction with other diagnostic tests. The assay is now available for all markets accepting the CE Mark. “The addition of our Elecsys Anti-p53 immunoassay will help clinicians...

Corbion has published its agenda for the upcoming Annual General Meeting of Shareholders (AGM) to be held on 19 May 2021. In view of the COVID-19 pandemic and the related measures Corbion has decided that the AGM will be a fully virtual meeting. This means that shareholders will be able to attend the AGM via webcast and may ask questions up to 72 hours prior to the AGM. For more details, please be referred to the convocation for the AGM. The full AGM agenda together with explanatory notes is available on Corbion’s website under Investor relations –> Shareholder information –> Shareholder meetings. AttachmentPress release AGM_agenda_ENG_2021

Corbion heeft de agenda gepubliceerd voor de aanstaande jaarlijkse Algemene Vergadering van Aandeelhouders (AvA), die op 19 mei 2021 wordt gehouden. In verband met de COVID-19 pandemie en de daarmee samenhangende maatregelen, heeft Corbion besloten dat het een volledig virtuele vergadering zal zijn. Dit betekent dat aandeelhouders kunnen deelnemen aan de AvA via een webcast en vragen kunnen indienen tot 72 uur voor aanvang van de AvA. Nadere details staan vermeld in de oproeping voor de AvA. De integrale AvA-agenda, inclusief toelichting bij de agendapunten, is beschikbaar op de website van Corbion onder Investor Relations –> Shareholder information –> Shareholder meetings. BijlagePress release AGM_agenda_NL_2021

Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAveraStudy is the last clinical step before seeking market approval in Europe in dry AMD Bionic vision Prima System has shown excellent results in improving vision              Paris, France, April 7, 2021 – 7.00 a.m. CEST – Pixium Vision SA (Euronext Growth Paris – FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces the successful first implantation of a patient in the PRIMAvera pivotal trial of its bionic vision Prima System for atrophic dry age-related macular degeneration (AMD). The PRIMAvera study was initiated in Q4 2020 and aims to confirm the safety and the benefits provided by the Prima System and is the...

According to his personal release, “The CMBS Market goes through cycles of uncertainty, and in the year plus since the COVID-19 Pandemic began, the CMBS Industry has showed true resiliency. Fitch expected the U.S. CMBS Market Delinquency rate to top out at about 8.25% to 8.75% for last year, but that prediction was high as the real number came in a 5.0%. Now of course government intervention and some debt relief play roles, but on the flip side of that coin if there was no pandemic, there would have been no crisis. Last month Fitch Ratings showed further decline in delinquencies, down to about 4.33%, and a further drop to 4% is expected here in the short-term.” “Due to our relationships with both banking and non-banking lenders, REITS, Family Offices, Hedge Funds and other Qualified Institutional Investors, the ‘race to the bottom’ for...

Investors were able to mull over the better-than-expected March job report last weekend, hence positively affecting the stock market. Another good news is the apparent economic recovery from the effects of the pandemic. They’re also looking forward to the commentary to be released by FOMC members about economic status. Though NASDAQ Futures, S&P Futures and the Dow Futures all fell back between 0.03% to 0.25%, these changes are within expectations. NASDAQ Composite Index led the market rally rising up by 225.49 basis points or 1.67% closing with 13,706. The tech giant managed to get past a critical hurdle, having its third day win close. They were able to bounce back from the previous slump and is expected to do better moving forwards. Google’s parent Alphabet managed to defend against a court case for using Oracle programming code....

HANGZHOU, China, April 06, 2021 (GLOBE NEWSWIRE) — Ebang International Holdings Inc. (Nasdaq: EBON, the “Company”), a blockchain technology company, today issued the following statement in response to the short seller report issued by Hindenburg Research (the “Hindenburg Report”), a short selling research firm, on April 6, 2021. Based on the review by the Company’s management team, we believe that the Hindenburg Report contain many errors, unsupported speculations and inaccurate interpretations of events.   The Company’s Board of Directors has also been made aware of the Hindenburg Report. The Board, together with its Audit Committee, intends to further review and examine the allegations and misinformation therein and will take whatever necessary and appropriate actions may be required to protect the interest of its shareholders....

The Management Board of AS Merko Ehitus, registry code 11520257, seated at Järvevana tee 9G, Tallinn, 11314, proposes to the shareholders to adopt resolutions without convening a meeting in accordance with § 2991 of the Commercial Code. The Management Board is making this proposal in order to avoid physical gatherings during the COVID-19 corona pandemic. The shareholders have the possibility to vote in favour or opposed to the resolutions either by mail or e-mail using a voting ballot, which is published on Merko Ehitus homepage group.merko.ee/en/general-meeting-of-shareholders and attached to the notice of adoption of resolutions on Nasdaq Baltic homepage (nasdaqbaltic.com). The filled in ballot together with the documents to enable identification of the shareholder and to certify the right of representation must be forwarded to the...